ESC 365 - Reducing residual risk in left ventricular assist device carriers: lessons from ARIES-HM3 trial

ESC Professional Premium Access

Reducing residual risk in left ventricular assist device carriers: lessons from ARIES-HM3 trial

Session: Showcasing successes in advanced heart failure

Topic: Clinical

Speaker: Professor M. Mehra (Boston, US)

Event: ESC Congress 2024

Congress Presentation

Add to my library

About the speaker

Professor Mandeep Mehra

Brigham and Women's Hospital, Harvard Medical School, Boston (United States of America)

37 presentations

8 followers

4 more presentations in this session

Temporary mechanical circulatory support as a bridge to transplant: what have we learned from the ASIS-TC registry?

Speaker: Doctor E. Barge Caballero (A Coruna, ES)

Real-world data on patients with left ventricular assist devices: the ELEVATE Registry

Speaker: Professor F. Gustafsson (Copenhagen, DK)

Update on heart transplantation

Speaker: Doctor M. Farrero Torres (Barcelona, ES)

Showcasing successes in advanced heart failure - discussion

Access the full session

Showcasing successes in advanced heart failure

Speakers: Professor M. Mehra, Doctor E. Barge Caballero, Professor F. Gustafsson, Doctor M. Farrero Torres

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources